Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4Z1 | Q86W10 | 3/20 | 0.50 |
| ▸ | CYP4F11 | Q9HBI6 | 1/20 | 0.50 |
| ▸ | CYP4F12 | Q9HCS2 | 1/20 | 0.50 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.49 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.49 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13453069 | 0.89 | MMP8 (0.44) | CYP4Z1CYP4F11CYP4F12CYP4F2CYP4A11 | |
| SCHEMBL1417279 | 0.89 | MMP8 (0.47) | CYP4Z1CYP4F11CYP4F12ALOX5MAPK1 | |
| SCHEMBL764890 | 0.84 | CYP4Z1 (0.56) | CYP4Z1CYP4F11CYP4F12CYP4F2CYP4A11 | |
| SCHEMBL12329325 | 0.82 | CYP4Z1 (0.53) | CYP4Z1CYP4F11CYP4F12CYP4F2CYP4A11 | |
| SCHEMBL1682154 | 0.79 | MMP8 (0.50) | MMP8SMN1; SMN2 | |
| SCHEMBL765861 | 0.79 | CYP4Z1 (0.55) | CYP4Z1CYP4F11CYP4F12CYP4F2CYP4A11 | |
| SCHEMBL1206853 | 0.79 | CYP4Z1 (0.56) | CYP4Z1CYP4F11CYP4F12CYP4F2CYP4A11 | |
| SCHEMBL23959915 | 0.78 | CYP4F2 (0.58) | CYP4Z1CYP4F11CYP4F12CYP4F2CYP4A11 | |
| SCHEMBL10289874 | 0.78 | CYP4F2 (0.62) | CYP4Z1CYP4F11CYP4F12CYP4F2CYP4A11 | |
| SCHEMBL765000 | 0.78 | CYP4F2 (0.62) | CYP4Z1CYP4F11CYP4F12CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120264925-A1 | METHOD FOR PRODUCING PYRAZOLE GLYCOSIDE DERIVATIVES | SANOFI (FR) | 2012-10-18 | — | — | US | disclosed |
| US-20120264925-A1 | METHOD FOR PRODUCING PYRAZOLE GLYCOSIDE DERIVATIVES | SANOFI (FR) | 2012-10-18 | — | — | US | disclosed |
| US-20120264925-A1 | METHOD FOR PRODUCING PYRAZOLE GLYCOSIDE DERIVATIVES | SANOFI (FR) | 2012-10-18 | — | — | US | disclosed |
| EP-2470551-A1 | METHOD FOR PRODUCING PYRAZOLE GLYCOSIDE DERIVATIVES | SANOFI (FR) | 2012-07-04 | — | — | EP | disclosed |
| EP-2298782-A1 | Method for producing pyrazole glycoside derivatives | Sanofi-Aventis (FR) | 2011-03-23 | — | — | EP | disclosed |
| EP-2298782-A1 | Method for producing pyrazole glycoside derivatives | Sanofi-Aventis (FR) | 2011-03-23 | — | — | EP | disclosed |
| WO-2011023755-A1 | METHOD FOR PRODUCING PYRAZOLE GLYCOSIDE DERIVATIVES | SANOFI-AVENTIS (FR) | 2011-03-03 | — | — | WO | disclosed |
| WO-2011023755-A1 | METHOD FOR PRODUCING PYRAZOLE GLYCOSIDE DERIVATIVES | SANOFI-AVENTIS (FR) | 2011-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264925-A1 | METHOD FOR PRODUCING PYRAZOLE GLYCOSIDE DERIVATIVES | CYP2F1, CYP4F3, F11 | CYP4Z1 177/4885CYP4F11 4/4885CYP4F12 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.